News and Analytical survey

Pfizer Inc. on Tuesday beat third-quarter expectations and lifted its outlook for the year, as the company benefits from new drug sales and folds in its recently-acquired Hospira business.

Firm says risk of tax hit from spinoff too high, pushes company to sell core business

Skeptical investors forced Square Inc. to sell shares in its initial public offering for less than the mobile-payments startup had hoped, further souring the market for new technology-company stock.

Carbonated version will launch in NYC, LA and Miami with wider rollout expected next year

It's a big day for central bank talk, China credit slumps and Euro-area problems are starting to simmer. Here are some of the things people in markets are talking about today.

Leave a request

and our specialist will contact you as soon as possible